Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price dropped 0.7% on Monday . The company traded as low as $4.48 and last traded at $4.50. Approximately 407,032 shares traded hands during trading, an increase of 211% from the average daily volume of 130,814 shares. The stock had previously closed at $4.53.
Ono Pharmaceutical Price Performance
The company has a 50 day moving average price of $4.68 and a 200 day moving average price of $5.22.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
See Also
- Five stocks we like better than Ono Pharmaceutical
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
